• Nefrosave tablet commonly contains N-acetylcysteine (NAC) plus taurine. These have antioxidant actions and may reduce oxidative stress and possibly albuminuria/protein leakage in some patients, especially diabetic or hypertensive CKD.
• Some branded variants contain different ingredients, such as NAC plus pyridoxamine or ketoanalogues. Ketoanalogues have a separate role: with a nephrologist-supervised low-protein diet, they can help maintain nutrition and lower nitrogenous waste in selected advanced CKD patients.

What it can and cannot do

• It may be prescribed as supportive therapy for proteinuria or renal protection.
• It is not proven to replace treatments that clearly slow CKD progression.
• It should not be relied on to reduce creatinine, reverse CKD, or avoid dialysis by itself. Evidence for NAC-taurine combinations in CKD remains limited and evolving, as summarized by Apollo Pharmacy's product information.

Treatments that matter more in CKD

• Tight blood-pressure control, often with an ACE inhibitor or ARB when albuminuria is present
• SGLT2 inhibitor therapy for eligible people, with or without diabetes
• Good diabetes control, salt restriction, avoiding NSAID painkillers, and monitoring potassium, eGFR, urine albumin, hemoglobin, and bone-mineral parameters.

Practical caution